ANGELA CARSON: Open Payments
NPI 1609240852 · RICHMOND, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$389 in 20 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $62 · 2025 $389
Food & beverage: $389
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 8 | $191 |
| Teva Pharmaceuticals USA, Inc. | 5 | $77 |
| ABBVIE INC. | 3 | $51 |
| Otsuka America Pharmaceutical, Inc. | 1 | $20 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $20 |
| Axsome Therapeutics, Inc. | 1 | $17 |
| Tris Pharma Inc | 1 | $14 |
Products named: COBENFY, UZEDY, VRAYLAR, ABILIFY MAINTENA, TRINTELLIX, Auvelity, Dyanavel XR.
Industry payments across VA — which companies pay providers there.
